The Demography and Etiology of Pediatric Enucleation in a Tertiary Eye Center in North China, 2001–2015

References

• Ye J, Lou L, Jin K, et al. Vision-related quality of life and appearance concerns are associated with anxiety and depression after eye enucleation: a cross-sectional study. PLoS One. 2015;10(8):e0136460. doi:10.1371/journal.pone.0136460.
   PubMed Web of Science ®Google Scholar
• Shuttleworth GN, Galloway P, Sparrow JM, Lane C. Ocular airgun injuries: a one-year surveillance study in the UK and Eire (BOSU). Eye (Lond). 2009;23(6):1370–1376. doi:10.1038/eye.2008.275.
   PubMed Web of Science ®Google Scholar
• Huang S, Crawford JB, Porco T, Rutar T. Clinicopathologic review of pediatric enucleations during the last 50 years. J AAPOS. 2010;14(4):328–333. doi:10.1016/j.jaapos.2010.05.006.
   PubMed Web of Science ®Google Scholar
• Moren Cross J, Griffin R, Owsley C, McGwin G Jr. Pediatric eye injuries related to consumer products in the United States, 1997–2006. J AAPOS. 2008;12(6):626–628. doi:10.1016/j.jaapos.2008.07.005.
   PubMed Web of Science ®Google Scholar
• Coody D, Banks JM, Yetman RJ, Musgrove K. Eye trauma in children: epidemiology, management, and prevention. J Pediatr Health Care. 1997;11:182–188. doi:10.1016/S0891-5245(97)90125-5.
   PubMedGoogle Scholar
• Porricha D, Aurora AL. Causes of enucleation and evisceration of eye balls in children: a clinic pathological study. Indian J Medical Sci. 1982;36:73–79.
   PubMedGoogle Scholar
• US Eye injury Registry. http://www.useironline.org/epidemiology. Accessed April 28, 2014.
   Google Scholar
• Cheng GY, Li B, Li LQ, et al. Review of 1375 enucleations in the Tongren eye centre, Beijing. Eye (Lond). 2008;22(11):1404–1409. doi:10.1038/sj.eye.6702919.
   PubMed Web of Science ®Google Scholar
• Yousuf SJ, Jones LS, Kidwell ED Jr. Enucleation and evisceration: 20 years of experience. Orbit. 2012;31(4):211–215. doi:10.3109/01676830.2011.639477.
   PubMedGoogle Scholar
• Ababneh OH, AboTaleb EA, Abu Ameerh MA, Yousef YA. Enucleation and evisceration at a tertiary care hospital in a developing country. BMC Ophthalmol. 2015;15:120. doi:10.1186/s12886-015-0108-x.
   PubMed Web of Science ®Google Scholar
• Enger C, Schein OD, Tielsch JM. Risk factors for ocular injuries caused by air guns. Arch Ophthalmol. 1996;114:469–474.
   PubMedGoogle Scholar
• Jones N. Eye injuries in sport: an increasing problem. Br J Sports Med. 1987;21:168–170.
   PubMedGoogle Scholar
• Knox FA, Chan WC, Jackson AJ, et al. A British ophthalmological surveillance unit study on serious ocular injuries from fireworks in the UK. Eye (Lond). 2008;22(7):944–947. doi:10.1038/sj.eye.6702778.
   PubMed Web of Science ®Google Scholar
• Cao H, Li L, Zhang M, Li H. Epidemiology of pediatric ocular trauma in the Chaoshan Region, China, 2001–2010. PLoS One. 2013;8(4):e60844. doi:10.1371/journal.pone.0060844.
   PubMed Web of Science ®Google Scholar
• Savar A, Andreoli MT, Kloek CE, Andreoli CM. Enucleation for open globe injury. Am J Ophthalmol. 2009;147(4):595–600. doi:10.1016/j.ajo.2008.10.017.
   PubMed Web of Science ®Google Scholar
• Pizzarello LD. Ocular trauma: time for action. Ophthalmic Epidemiol. 1998;5:115–116.
   PubMedGoogle Scholar
• Sengupta S, Krishnakumar S, Biswas J, et al. Fifteen-year trends in indications for enucleation from a tertiary care center in South India. Indian J Ophthalmol. 2012;60(3):179–182. doi:10.4103/0301-4738.95867.
   PubMed Web of Science ®Google Scholar
• Vemuganti GK, Jalali S, Honavar SG, Shekar GC. Enucleation in a tertiary eye care centre in India: prevalence, current indications and clinicopathological correlation. Eye(Lond). 2001;15(Pt 6):760–765. doi:10.1038/eye.2001.245.
   Google Scholar
• Shields CL, De Potter P, Himelstein BP, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114(11):1330–1338.
   PubMedGoogle Scholar
• Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276–2280. doi:10.1016/j.ophtha.2006.06.018.
   PubMed Web of Science ®Google Scholar
• Zhao J, Li S, Shi J, Wang N. Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China. Br J Ophthalmol. 2011;95(10):1372–1375. doi:10.1136/bjo.2010.191130.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118(10):2081–2087. doi:10.1016/j.ophtha.2011.03.013.
   PubMed Web of Science ®Google Scholar
• Shields CL, Kaliki S, Al-Dahmash S, et al. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation. Retina. 2013;33(10):2103–2109. doi:10.1097/IAE.0b013e318295f783.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Daniels AB, Marr BP, et al. Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma. PLoS One. 2016;11(1):e0146582. doi:10.1371/journal.pone.0146582.
   PubMed Web of Science ®Google Scholar
• Mallipatna AC, Dimaras H, Chan HS, et al. Periocular topotecan for intraocular retinoblastoma. Arch Ophthalmol. 2011;129(6):738–745. doi:10.1001/archophthalmol.2011.130.
   PubMedGoogle Scholar
• Munier FL, Gaillard MC, Balmer A, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96(8):1078–1083. doi:10.1136/bjophthalmol-2011-301450.
   PubMed Web of Science ®Google Scholar
• Lumbroso-Le Rouic L, Aerts I, Hajage D, et al. Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy. Eye (Lond).
   Web of Science ®Google Scholar